Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | No | No |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Onconetix, Inc. |
| Arcturus Therapeutics Holdings Inc. |
| iTeos Therapeutics, Inc. |
| Applied Therapeutics, Inc. |
| Taysha Gene Therapies, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| ONCO | ARCT | ITOS | APLT | TSHA | XFOR | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -234% | -31% | -23% | NM | -122% | -102% | ||
| Fiscal Year - 1 | NA | -11% | -18% | NA | -294% | NA | ||
| Fiscal Year - 2 | NA | 4% | 16% | NA | -345% | NA | ||
| Fiscal Year - 3 | NA | -65% | 49% | NA | NA | NA | ||
| Fiscal Year - 4 | NA | -34% | NA | NA | NA | -62% | ||
| Fiscal Year - 5 | NA | -132% | NA | NA | NA | NA | ||
| Average | -234% | -45% | 6% | NA | -254% | -82% | ||
| Median | -234% | -33% | -1% | NA | -294% | -82% | ||
| Benchmarks | Ticker | |||||||
| Onconetix, Inc. | NasdaqCM:ONCO | |||||||
| Arcturus Therapeutics Holdings Inc. | NasdaqGM:ARCT | |||||||
| iTeos Therapeutics, Inc. | NasdaqGM:ITOS | |||||||
| Applied Therapeutics, Inc. | NasdaqGM:APLT | |||||||
| Taysha Gene Therapies, Inc. | NasdaqGS:TSHA | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | ONCO | ARCT | ITOS | APLT | TSHA | XFOR | ||
| Latest Fiscal Year | Dec-23 | Dec-24 | Dec-24 | Dec-23 | Dec-24 | Dec-24 | ||
| LTM Period | Sep-24 | Dec-24 | Dec-24 | Sep-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 2 | 152 | 35 | (0) | 8 | 3 | ||
| Fiscal Year | 0 | 152 | 35 | 10 | 8 | 3 | ||
| Fiscal Year - 1 | NA | 167 | 13 | NA | 15 | NA | ||
| Fiscal Year - 2 | NA | 206 | 268 | NA | 3 | NA | ||
| Fiscal Year - 3 | NA | 12 | 345 | NA | NA | NA | ||
| Fiscal Year - 4 | NA | 10 | NA | NA | NA | 3 | ||
| Fiscal Year - 5 | NA | 21 | NA | NA | NA | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | (52) | (81) | (134) | (187) | (89) | (37) | ||
| Fiscal Year | (37) | (81) | (134) | (120) | (89) | (37) | ||
| Fiscal Year - 1 | (14) | (30) | (113) | (83) | (112) | (101) | ||
| Fiscal Year - 2 | (4) | 9 | 97 | (106) | (166) | (96) | ||
| Fiscal Year - 3 | (2) | (204) | 215 | (94) | (175) | (103) | ||
| Fiscal Year - 4 | (1) | (72) | (43) | (46) | (60) | (62) | ||
| Fiscal Year - 5 | NA | (26) | (27) | (17) | (4) | (53) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 28 | 429 | 668 | 45 | 173 | 147 | ||
| Latest Fiscal Quarter | 62 | 344 | 687 | 107 | 160 | 146 | ||
| Fiscal Year | 88 | 344 | 687 | 55 | 160 | 146 | ||
| Fiscal Year - 1 | 26 | 429 | 668 | 38 | 173 | 147 | ||
| Fiscal Year - 2 | 3 | 450 | 755 | 90 | 126 | 156 | ||
| Fiscal Year - 3 | 5 | 393 | 885 | 105 | 214 | 117 | ||
| Fiscal Year - 4 | 6 | 476 | 345 | 48 | 259 | 123 | ||
| Fiscal Year - 5 | NA | 82 | 31 | 20 | 0 | 161 | ||
| Fiscal Year - 6 | NA | 44 | 27 | 3 | NA | 10 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 10 | 279 | 575 | (11) | 75 | 51 | ||
| Latest Fiscal Quarter | 34 | 241 | 590 | 6 | 72 | 22 | ||
| Fiscal Year | (6) | 241 | 590 | (17) | 72 | 22 | ||
| Fiscal Year - 1 | 22 | 279 | 575 | 4 | 75 | 51 | ||
| Fiscal Year - 2 | 1 | 270 | 663 | 63 | 1 | 74 | ||
| Fiscal Year - 3 | 5 | 228 | 553 | 82 | 95 | 64 | ||
| Fiscal Year - 4 | 6 | 397 | 323 | 33 | 251 | 73 | ||
| Fiscal Year - 5 | NA | 26 | (36) | (20) | (0) | 129 | ||
| Fiscal Year - 6 | NA | 14 | (11) | (4) | NA | (77) | ||